Liu L, Cheng Z, Wang L, et al
All this can be provided by glucose metabolism and the coupling of cyclic PPP with downstream glycolysis and pyruvate metabolized in the citric acid cycle, or supplemented by proline metabolism in mitochondria
7 In patients who meet these criteria, the ADA preferably recommends use of a GLP-1 RA with proven cardiovascular benefit or an SGLT-2 inhibitor with proven cardiovascular benefit provided they have adequate kidney function
Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Rivers LJ, Feldman R et al
GLP-1 medications are not recommended during breastfeeding because limited data exists on whether these compounds pass into breast milk and what effects they might have on a nursing infant
J Alzheimers Dis Rep 9: 25424823251342182